These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1090 related articles for article (PubMed ID: 26091634)

  • 1. A Historical View and Vision into the Future of the Field of Safety Pharmacology.
    Bass AS; Hombo T; Kasai C; Kinter LB; Valentin JP
    Handb Exp Pharmacol; 2015; 229():3-45. PubMed ID: 26091634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and lessons learned since implementation of the safety pharmacology guidance ICH S7A.
    Valentin JP; Bass AS; Atrakchi A; Olejniczak K; Kannosuke F
    J Pharmacol Toxicol Methods; 2005; 52(1):22-9. PubMed ID: 15961324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benchmarking safety pharmacology regulatory packages and best practice.
    Lindgren S; Bass AS; Briscoe R; Bruse K; Friedrichs GS; Kallman MJ; Markgraf C; Patmore L; Pugsley MK
    J Pharmacol Toxicol Methods; 2008; 58(2):99-109. PubMed ID: 18692579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety pharmacology in 2010 and beyond: survey of significant events of the past 10 years and a roadmap to the immediate-, intermediate- and long-term future in recognition of the tenth anniversary of the Safety Pharmacology Society.
    Bass AS; Vargas HM; Valentin JP; Kinter LB; Hammond T; Wallis R; Siegl PK; Yamamoto K
    J Pharmacol Toxicol Methods; 2011; 64(1):7-15. PubMed ID: 21689769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety pharmacology in focus: new methods developed in the light of the ICH S7B guidance document.
    Pugsley MK; Curtis MJ
    J Pharmacol Toxicol Methods; 2006; 54(2):94-8. PubMed ID: 16806993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origins, practices and future of safety pharmacology.
    Bass A; Kinter L; Williams P
    J Pharmacol Toxicol Methods; 2004; 49(3):145-51. PubMed ID: 15172010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory drug safety: a discovery strategy to reduce attrition in development.
    Bass AS; Cartwright ME; Mahon C; Morrison R; Snyder R; McNamara P; Bradley P; Zhou YY; Hunter J
    J Pharmacol Toxicol Methods; 2009; 60(1):69-78. PubMed ID: 19422924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical-pharmacological aspects to accelerate the development process from the preclinical to the clinical phase/1st communication: The contribution of clinical pharmacology].
    Kuhlmann J
    Arzneimittelforschung; 2004; 54(5):251-8. PubMed ID: 15212186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICH S7B draft guideline on the non-clinical strategy for testing delayed cardiac repolarisation risk of drugs: a critical analysis.
    Cavero I; Crumb W
    Expert Opin Drug Saf; 2005 May; 4(3):509-30. PubMed ID: 15934857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-clinical evaluation of ventricular repolarization (ICH S7B): results of an interim survey of international pharmaceutical companies.
    Friedrichs GS; Patmore L; Bass A
    J Pharmacol Toxicol Methods; 2005; 52(1):6-11. PubMed ID: 15975833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Diplomate in Safety Pharmacology (DSP) certification scheme.
    Authier S; Curtis MJ; Soloviev M; Redfern WS; Kallman MJ; Hamlin RL; Leishman DJ; Valentin JP; Koerner JE; Vargas HM; Botchway A; Correll K; Pugsley MK
    J Pharmacol Toxicol Methods; 2015; 75():1-4. PubMed ID: 25959882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodological innovations expand the safety pharmacology horizon.
    Pugsley MK; Curtis MJ
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):59-62. PubMed ID: 22617368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal studies in safety pharmacology and toxicology: A survey conducted in the top 15 pharmaceutical companies.
    Benjamin A; Gallacher DJ; Greiter-Wilke A; Guillon JM; Kasai C; Ledieu D; Levesque P; Prelle K; Ratcliffe S; Sannajust F; Valentin JP
    J Pharmacol Toxicol Methods; 2015; 75():101-10. PubMed ID: 25637943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in safety pharmacology: posters presented at the annual meetings of the Safety Pharmacology Society 2001-2010.
    Redfern WS; Valentin JP
    J Pharmacol Toxicol Methods; 2011; 64(1):102-10. PubMed ID: 21635957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods in safety pharmacology in focus.
    Pugsley MK; Gallacher DJ; Towart R; Authier S; Curtis MJ
    J Pharmacol Toxicol Methods; 2008; 58(2):69-71. PubMed ID: 18707009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodology used in safety pharmacology: appraisal of the state-of-the-art, the regulatory issues and new directions.
    Pugsley MK
    J Pharmacol Toxicol Methods; 2005; 52(1):1-5. PubMed ID: 15982903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysics and Molecular Biology of Cardiac Ion Channels for the Safety Pharmacologist.
    Pugsley MK; Curtis MJ; Hayes ES
    Handb Exp Pharmacol; 2015; 229():149-203. PubMed ID: 26091640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rethinking Giftedness and Gifted Education: A Proposed Direction Forward Based on Psychological Science.
    Subotnik RF; Olszewski-Kubilius P; Worrell FC
    Psychol Sci Public Interest; 2011 Jan; 12(1):3-54. PubMed ID: 26168418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.